BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 34504109)

  • 1. Cholangiocarcinoma.
    Brindley PJ; Bachini M; Ilyas SI; Khan SA; Loukas A; Sirica AE; Teh BT; Wongkham S; Gores GJ
    Nat Rev Dis Primers; 2021 Sep; 7(1):65. PubMed ID: 34504109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis, diagnosis, and management of cholangiocarcinoma.
    Ilyas SI; Gores GJ
    Gastroenterology; 2013 Dec; 145(6):1215-29. PubMed ID: 24140396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma.
    Sarcognato S; Sacchi D; Fassan M; Fabris L; Cadamuro M; Zanus G; Cataldo I; Capelli P; Baciorri F; Cacciatore M; Guido M
    Pathologica; 2021 Jun; 113(3):158-169. PubMed ID: 34294934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current diagnostic and management options in perihilar cholangiocarcinoma.
    Rizvi S; Gores GJ
    Digestion; 2014; 89(3):216-24. PubMed ID: 24860985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of cholangiocarcinoma: a hepatologist's perspective.
    Qureshi K; Jesudoss R; Al-Osaimi AM
    Curr Gastroenterol Rep; 2014 Oct; 16(10):412. PubMed ID: 25183579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of cholangiocarcinoma.
    Bergquist A; von Seth E
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
    Duggan WP; Brosnan C; Christodoulides N; Nolan N; Kambakamba P; Gallagher TK
    Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
    Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
    JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging molecular therapeutic targets for cholangiocarcinoma.
    Ilyas SI; Gores GJ
    J Hepatol; 2017 Sep; 67(3):632-644. PubMed ID: 28389139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation for hilar cholangiocarcinoma.
    Heimbach JK; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB; Gores GJ
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S65-8. PubMed ID: 15382214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of perihilar cholangiocarcinoma in the era of multimodal therapy.
    Valero V; Cosgrove D; Herman JM; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):481-95. PubMed ID: 22928900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Fevery J; Verslype C; Lai G; Aerts R; Van Steenbergen W
    Dig Dis Sci; 2007 Nov; 52(11):3123-35. PubMed ID: 17431781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocarcinoma--current treatment options.
    Friman S
    Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma Insights: Established Foundations and Cutting-Edge Innovations from Dr. James Cleary's Pioneering Research.
    Cortiana V; Chorya H; Joshi M; Kannan S; Mahendru D; Vallabhaneni H; Coloma HS; Leyfman Y; Park CH
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.